300 related articles for article (PubMed ID: 17595285)
1. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
Canut A; Martín-Herrero JE; Labora A; Maortua H
J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Sethi S
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S177-85. PubMed ID: 15942884
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
Chelidze K; Jgarkava M
Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
6. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
7. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
Martinez FJ; Han MK; Flaherty K; Curtis J
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):101-24. PubMed ID: 16441213
[TBL] [Abstract][Full Text] [Related]
8. Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: a therapeutic outcomes model.
Canut A; Martin-Herrero JE; Maortua H; Labora A; Isla A; Rodriguez-Gascon A
J Chemother; 2009 Aug; 21(4):408-13. PubMed ID: 19622459
[TBL] [Abstract][Full Text] [Related]
9. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.
Larsen MV; Janner JH; Nielsen SD; Friis-Møller A; Ringbaek T; Lange P
Scand J Infect Dis; 2009; 41(1):26-32. PubMed ID: 18855228
[TBL] [Abstract][Full Text] [Related]
10. A mathematical therapeutic outcomes model for sinusitis.
Poole MD
Otolaryngol Head Neck Surg; 2004 Jan; 130(1 Suppl):46-50. PubMed ID: 14726905
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
12. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.
Ranieri P; Bianchetti A; Margiotta A; Virgillo A; Clini EM; Trabucchi M
J Am Geriatr Soc; 2008 May; 56(5):909-13. PubMed ID: 18384582
[TBL] [Abstract][Full Text] [Related]
13. Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
Sethi S; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Wilson R
Infection; 2016 Feb; 44(1):65-76. PubMed ID: 26370552
[TBL] [Abstract][Full Text] [Related]
14. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Pasqua F; Biscione G; Crigna G; Cazzola M
Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
[TBL] [Abstract][Full Text] [Related]
15. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
16. Rising to the challenge of resistance: a case study-based discussion.
Housset B
Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S11-6. PubMed ID: 17307651
[TBL] [Abstract][Full Text] [Related]
17. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
Zhou YQ; Xie CM; Chen DM; Chen L
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
[TBL] [Abstract][Full Text] [Related]
19. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
Kahn JB; Khashab M; Ambruzs M
Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
